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Stæhr M, Hansen PB, Madsen K, Vanhoutte PM, Nüsing RM,
Jensen BL. Deletion of cyclooxygenase-2 in the mouse increases
arterial blood pressure with no impairment in renal NO production in
response to chronic high salt intake. Am J Physiol Regul Integr Comp
Physiol 304: R899–R907, 2013. First published March 27, 2013;
doi:10.1152/ajpregu.00103.2012.—Experiments were designed to test
the hypothesis that cyclooxygenase-2 (COX-2) activity attenuates the
blood pressure increase during high NaCl intake by stimulation of
endothelial nitric oxide synthase (eNOS)-mediated NO synthesis in
the kidney medulla. COX-2/ (C57BL6) an COX-2/ mice were
fed a diet with 0.004% (low salt, LS) or 4% (high salt, HS) NaCl for
18 days. Arterial blood pressure was recorded continuously using
indwelling catheters. Food and water intake and diuresis were mea-
sured in metabolic cages. Urine osmolality and excretion of electro-
lytes, cGMP, cAMP, and NOx were determined, as well as plasma
NOx and cGMP. There was a significant dependence of blood pres-
sure on salt intake and genotype: COX-2/ exhibited higher blood
pressure than COX-2/ both on HS and LS intake. COX-2/
littermates displayed an increase in blood pressure on HS versus LS
(102.3  1.1 mmHg vs. 91.9  0.9 mmHg) day and night. The mice
exhibited significant blood pressure increases during the awake phase
(night) that were larger in COX-2/ on HS diet compared with
COX-2/. Water intake, diuresis, Na, and osmolyte excretions and
NOx and cGMP excretions were significantly and similarly elevated
with HS in COX-2/ and COX-2/. In summary, C57BL6 mice
exhibit a salt intake-dependent increase in arterial blood pressure with
increased renal NO production. COX-2 activity has a general lowering
effect on arterial blood pressure. COX-2 dampens NaCl-induced
increases in arterial blood pressure in the awake phase. In conclusion,
COX-2 activity attenuates the changes in nocturnal blood pressure
during high salt intake, and COX-2 activity is not necessary for
increased renal nitric oxide formation during elevated NaCl intake.
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PROSTAGLANDINS contribute to the regulation of blood pressure
partly because they promote renal sodium excretion by their
effects on the tubular epithelium and on medullary blood flow
(9). A critical step in the production is the transformation of
arachidonic acid to short-lived PGG2/PGH2, catalyzed by cy-
clooxygenase (COX). Two isoforms of this enzyme have been
identified: COX-1 and COX-2 (3, 36), initially thought to be
constitutive and inducible, respectively. But in the wake of the
severe side effects (hypertension, thrombosis, and stroke) as-
sociated with the clinical use of specific COX-2 inhibitors, a
more constitutive role for COX-2 in vascular homeostasis and
kidney function has become apparent (4, 10). COX-2, micro-
somal PGE synthase (mPGES-1), and tissue/urine PGE2 levels
are increased by high salt intake in the medulla (12, 13, 16, 39,
40). Local inhibition of COX-2 only in the medulla leads to
hypertension during high salt intake in rats (40, 42). Disruption
of mPGES-1 in mice leads to hypertension and NaCl retention
when combined with a high-salt diet (14). Together, the data
indicate a NaCl-induced, blood pressure-protective homeo-
static action of medullary COX-2-mPGES-1. A similar protec-
tive action of the medullary nitric oxide (NO) system has been
shown. Of the three different NO synthases (NOS), endothelial
NOS (eNOS) (23), neuronal NOS (nNOS) (1, 27), and induc-
ible NOS (iNOS), particularly eNOS is expressed in the tubular
and vascular segments of the renal medulla (34). The infusion
of the NOS inhibitor NG-nitro-L-arginine methyl ester (L-
NAME) into the medulla decreases renal medullary blood flow
and sodium and water excretion (22), whereas eNOS/ mice
display salt-sensitive hypertension (20). PGE2-induced relax-
ations of isolated arteries depend on the presence of the
endothelium and eNOS (11). The existence of a serial coupling
between the renal medullary production of PGE2 and NO
synthase activity is suggested by the attenuated urinary excre-
tion of cGMP and nitrite/nitrate in mPGES-1/ mice (13, 14).
The present study was designed to test the hypothesis that
increased dietary salt intake leads to COX-2 and PGE2-depen-
dent stimulation of eNOS-mediated NO production in the renal
medulla. To address the hypothesis, high- or low-salt diets
were administered chronically to undisturbed, conscious COX-
2/ and COX-2/ mice, and their effects on blood pressure
and heart rate were measured continuously with indwelling
catheters. In addition, the effect of salt intake on renal medul-
lary NO synthase mRNA and protein expressions were deter-
mined, and indices of systemic and renal NO production (NOx
and cGMP) were measured in these mice.
MATERIALS AND METHODS
Animals. All animal experiments conformed to the “Guide for the
Care and Use of Laboratory Animals” published by the National
Institutes of Health (NIH Publication No. 85-23, Revised 1996) and
the Danish national guidelines. The mice were housed at the Biomed-
ical Laboratory, University of Southern Denmark and kept on a 12:12
h light-dark cycle at a controlled temperature (21  1°C) and with
free access to standard pathogen-free chow (Altromin, Lage, Ger-
many) and tap water.
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Studies were conducted in male (n  21) and female (n  18)
COX-2/ and COX-2/ mice (20–25 g) at 8–9 wk of age. The
mice were originally developed by Dinchuk et al. (4), and heterozy-
gous breeding pairs were obtained from Jackson Laboratories (strain
name; B6;129S-Ptgs2tm1Jed/J) on a predominant C57BL6 genetic
background and further backcrossed for nine generations (C57BL6)
before experiments. Genotyping was performed with DNA from tail
biopsies as described (8) using a REDExtract-NAmp tissue PCR kit
(Sigma-Aldrich, Copenhagen, Denmark).
Salt diet. Mice were divided into four groups: group I: COX-2/,
low-salt (LS) diet (0.004% NaCl); group II: COX-2/, high-salt
(HS) (4% NaCl); group III: COX-2/, LS diet (0.004% NaCl); and
group IV: COX-2/, HS diet (4% NaCl). The LS diet (0.004%) was
purchased from Ziegler Bros (Gardners, PA) and grinded into powder.
To obtain HS diet, 4% NaCl was added. The NaCl content was
confirmed by flame photometry of supernatants. The mice were fed
either a HS or a LS diet for 8 days before surgery and throughout the
blood pressure measurements, for a total of 17 days.
Arterial blood pressure measurement. The mice were anesthetized
with an intraperitoneal injection of ketamine (50 mg/kg) and xylazine
(10 mg/kg), and supplementation was given during surgery if needed.
A catheter was placed in the femoral artery for the measurement of
arterial blood pressure and heart rate, as described (33). After surgery,
the catheter was attached to a swivel (Instech Laboratories, Plymouth
Meeting, PA) so that the mice were able to move freely in their cage.
They were allowed to recover for 5 days after operation, during which
period the arterial catheters were kept open with infusion of 10 l/h
heparin solution (100 units in glucose). Before the experiment the
arterial line was connected to a pressure transducer (Föhr Medical
Instruments, Hesen, Germany), and data were collected at 200 Hz
using Lab View software (National Instruments, Austin, TX). Systolic
and diastolic blood pressures together with heart rate were measured
continuously for 4 days (days 14–17). Mean values for every 5 min
were generated and mean values for day (light period) and night (dark
period) were calculated. The diurnal variation in blood pressure and
heart rate in the four groups was expressed as the mean difference
between dark and light period. At the end of the experiment a blood
sample (200 l) was collected. The mice were anesthetized by an
infusion of pentobarbital and then euthanized, and kidneys and aortas
were harvested. The kidneys were divided into cortex and medulla and
tissues were stored at 80°C until further analysis.
A separate group of mice [COX-2/ and wild-type (C57BL6), 6
wk of age] on normal salt diet were anesthetized and then euthanized,
and hearts were harvested for determination of the heart-to-body
weight ratio.
Metabolic cages. In separate experiments, mice were divided into
four groups (I, II, III, IV). Each group received either a HS or a LS diet
for 12 days before the experiment, allowing the mice to achieve a
sodium balance in steady state. Mice were then placed in individual
metabolic cages for 5 days, and the original salt diet continued until
the end of the experiment. After a 3-day run-in period, body weight,
food and water intake, and urine excretion were measured for 2
consecutive days. The urine from days 13 to 15 was discarded but the
24-h urine samples of days 16 and 17 (corresponding to the last days
of blood pressure measurement) were collected. At the end of the
experiment a blood sample was taken.
Plasma and urine analysis. Urine osmolality was determined by
freeze-point depression (Osmomat 030-D, Gonotec, Bie and Berntsen,
Herlev, Denmark). Na and K concentrations were determined by
flame photometry (model IL 943, Instrumentation Laboratory, Lex-
ington, MA). The plasma renin concentration was measured by
radioimmunoassay as described (26).
Urine and plasma NOx were determined using a Nitrate/Nitrite
Colorimetric Assay Kit (780001, Cayman Chemical, Aarhus, Den-
mark). Nitrate was converted to nitrite utilizing nitrate reductase,
followed by the addition of Griess Reagents converting nitrite into a
deep purple azo compound. Samples were diluted 1:5 (urine) and 1:2
(plasma) and run in duplicate. Urine (unacetylated, diluted 1:500) and
plasma (acetylated, diluted 1:2,500) cGMP were measured using
enzyme immunoassay kits (581001, Cayman Chemical). Urine cAMP
was measured using enzyme immunoassay kits (581021, Cayman
Chemical). Samples were unacetylated, diluted 1:500, and run in
duplicate.
Prostanoids were extracted from 100-l plasma samples and
amounts were determined by LC/MS-MS as described (29). In brief,
for liquid-liquid extraction, samples were incubated twice with 600 l
ethylacetate, and the organic phase was removed at 45°C under
nitrogen. For reconstitution 50 l of acetonitrile-water-formic acid
(20:80:0.0025, vol/vol, pH 4.0) were used, and after centrifugation for
5 min at 18,000 g samples were used for injection. Prostanoids were
separated with a Synergi 150  2 mm Hydro-RP column (Phenome-
nex, Aschaffenburg, Germany) and determined with an API 4000
triple quadrupole mass spectrometer (AB Sciex, Darmstadt, Ger-
many).
Polymerase chain reaction. Messenger RNA was isolated by phase
separation from whole aortas and kidney cortex and medulla using
TRIzol Reagent. The RNA was quantified by spectrophotometry and
stored at 80°C. cDNA was made using the iScript cDNA Synthesis
Kit (Bio-Rad, Copenhagen, Denmark). Quantitative PCR was per-
formed with primer sets shown in Table 1 using 50 ng cDNA in
duplicate mixed with iQ SYBR Green Supermix (Bio-Rad). Water
and samples without reverse transcriptase were used as negative
controls. The mixture was denatured for 3 min at 95°C, and 44 cycles
were run on a Stratagene Mx3000 (AH Diagnostics, Aarhus, Den-
mark) as follows: denaturation at 95°C for 30 s, and annealing and
extension, 45 s at 60°C [40 cycles, 95°C for 20 s and 60°C for 20 s
for atrial natriuretic peptide (ANP)]. A melting curve analysis con-
firmed specificity postrun for each plate setup, and a standard curve
was constructed by plotting threshold cycle (Ct values) against serial
dilutions. Purified PCR product was used to generate a standard curve.
Western blotting. Kidney medulla samples were homogenized in
ice-cold sucrose-imidazole buffer containing 0.3 M sucrose, 25 mM
imidazole, 1 mM EDTA-disodium salt, 0.4 M Pefabloc, 2.1 mM
leupeptin, 1 mM Na-ortho-vanadate, 0.2 M NaF, and 0.082 g/l
okadaic acid. Protein concentrations were determined using the Brad-
ford Protein Assay (Bio-Rad).
Table 1. Primer sequences
Product Sense Anti-Sense Size (bp)
eNOS GAG-AGC-GAG-CTG-GTG-TTT-G TGA-TGG-CTG-AAC-GAA-GAT-TG 187
iNOS ACT-GTG-TGC-CTG-GAG-GTT-CT TCT-CTG-CCT-ATC-CGT-CTC-GT 177
nNOS ACC-AGC-TCT-TCC-CTC-TAG-CC GCC-ATA-GAT-GAG-CTC-CGT-GT 158
COX-2 GGC-GTT-CAA-CTG-AGC-TGT GGA-ATT-CTC-ACT-GGC-TTA-TGT-AGA-G 241
ANP CCT-GTG-TAC-AGT-GCG-GTG-TC ACA-CAC-CAC-AAG-GGC-TTA-GG 455
GAPDH TGA-TGG-CAT-GGA-CTG-TGG CAG-CAA-TGC-ATC-CTG-CAC 103
Tbcc GAC-TCC-TTC-CTG-AAC-CTC-TGG GGA-GGC-CAT-TCA-AAA-CTT-CA 62
Sequences of DNA oligo primers used in PCR analyses. eNOS, endothelial nitric oxide synthase (NOS); iNOS, inducible NOS; nNOS, neuronal NOS, COX-2,
cyclooxygenase-2; ANP, atrial natriuretic peptide; Tbcc, tubulin folding cofactor C.
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Thirty micrograms of protein were separated by SDS-PAGE (4–
15% Tris·HCl gels, Bio-Rad) and transferred to a 0.45-m pore-size
Immobilin-P PVDF-membrane (Millipore, Copenhagen, Denmark)
using the XCell SureLock Mini-Cell system (Invitrogen, Naerum,
Denmark). Membranes were blocked with 5% nonfat milk in TBST
[20 mM Tris-base (Sigma), 137 nM NaCl, 0.05% Tween 20 (Sigma),
pH 7.6] for 1 h under gentle shaking. Membrane were then incubated
with primary antibody; rabbit polyclonal to eNOS (ab5589, Abcam,
Cambridge, UK) or rabbit monoclonal to phospho-eNOS (Thr495)
(05–811, Upstate) diluted 1:1,000 and 1:500 respectively in 5% milk
in TBST and incubated overnight at 4°C. This was followed by
incubation with a horseradish peroxidase-conjugated secondary anti-
body directed against rabbit IgG (diluted 1:2,000, goat anti-rabbit,
P0448, Dako, Glostrup, Denmark) for 1 h at RT. Labelling was
visualized by the ECL plus Western Blotting Detection System
(Amersham Biosciences/GE Healthcare, Munich, Germany). Optical
densities of the bands were determined with Quantity One 4.03
software (Bio-Rad). To confirm equal protein loading membranes
were stripped (TBST, pH 2) 2  10 min, blocked, and loaded with an
antibody against -actin (1:2,000, Abcam, Cambridge, UK).
Statistical evaluation. Blood pressure and heart rate data were
integrated over 12-h periods (light:dark periods) for days 14 to 17 and
mean values for each group were calculated. Data were classified
within two categorical variables or factors: salt intake and genotype.
Hence, two-way ANOVA was applied to determine the significance of
the main effects as well as the interaction of the two factors, followed
by Bonferroni post hoc test to assess the difference between groups.
Specifically, changes in mean values of blood pressure and heart rate
were compared by two-way ANOVA followed by Bonferroni’s mul-
tiple comparison test. Delta values of blood pressure (difference
between night and day) were calculated and analyzed by two-way
ANOVA followed by post hoc analysis with Bonferroni’s multiple
comparison test. Data for metabolic parameters and expression levels
of specific mRNA and protein molecules were analyzed by two-way
ANOVA followed by post hoc analysis with Bonferroni correction.
P values for interaction, genotype, and diet are reported for each data
set in the legends to figures, and significance from the Bonferroni
multiple comparison post hoc analysis is indicated with an asterisk. P
values 	0.05 were considered to indicate statistically significant
differences.
RESULTS
Arterial blood pressure and heart rate. Mean arterial blood
pressure (MAP) was increased significantly by the high-salt
diet in COX-2/ (Fig. 1A), during both the light and dark
phases, and in COX-2/ mice only during the dark phase
(Fig. 1B), in the 4 days recording period. Heart rate was not
significantly different between groups at any time during the 4
days (Fig. 1C). A higher arterial blood pressure was observed
in COX-2/ mice compared with COX-2/ mice at both
levels of salt intake primarily during the dark (active) phase
(Fig. 1, D and E). MAP, averaged over the whole recording
period, was increased by high-salt diet in both genotypes and
was significantly higher in the COX-2/ mice at both levels
of NaCl intake compared with COX-2/ littermate controls
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Fig. 1. Effect of high- and low-salt diet (HS, 4%
NaCl and LS, 0.004% NaCl, 18 days) on mean
arterial blood pressure (MAP) and heart rate mea-
sured by chronic indwelling arterial catheters in con-
scious, freely moving COX-2/ and COX-2/
mice. Mice were divided into four groups. Group I:
COX-2/, LS (n  10); group II: COX-2/, HS
(n  11); group III: COX-2/, LS (n  8); and
group IV: COX-2/, HS (n  10). Bar graphs
depict means  SE. Statistical evaluation by two-
way ANOVA followed by Bonferroni posthoc test.
*Statistically significant difference between groups
at P 	 0.05 (Bonferroni multiple comparison post hoc
test). Time course of MAP from day 14 to night 17
(day, 0–12 h and night, 12–24 h) for COX-2/ (A)
and COX-2/ (B) on HS and LS diet. C: time course
of heart rate (days 14–17) in COX-2/ and / mice
on LS and HS diet. Time course of MAP from day 14
to night 17 for COX-2/ and COX-2/ on LS (D)
and HS diet (E). F: averages of MAP for days 14–17
(24 h) in COX-2/ and COX-2/ mice on HS and
LS diet. P values for interaction (I), genotype (G), and
diet (D) for F: I, 0.943; G, P 	 0.0001; and D, P 	
0.0001.
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(Fig. 1F). COX-2/ at high NaCl intake displayed highest
MAP value (Fig. 1F).
MAP was significantly elevated in the dark phase (night-
“N”) in all groups (Fig. 2A), and the difference in MAP (
)
between night and day was significantly augmented by high
salt intake in both genotypes (Fig. 2B) (interaction genotype 
diet; P  0.01). The difference in MAP between night and day
was significantly higher in COX-2/ on high-salt diet com-
pared with all other groups (Fig. 2B). The heart-to-body weight
ratio was significantly higher in adult COX-2/ mice (0.64 
0.05 g, n  7) on continuous normal salt diet compared with
wild-type mice (0.49 0.01 g, n 8) on normal salt diet (data
not shown). No significant difference in MAP was observed
between male and female mice in any of the categories geno-
type and salt intake (Fig. 2, C–F).
Effect of salt intake on diuresis, urine osmolality, urine K and
Na excretion, plasma renin and 6-keto-PGF1 concentrations. The
mean food intake (days 16 and 17, when urine was collected)
was not different between groups: COX-2/ (LS; 3.96 
0.23, HS; 3.85  0.30) and COX-2/ (LS; 3.57  0.28, HS;
3.47  0.11) g/day. Water intake was significantly elevated with
a high-salt diet in COX-2/ and COX-2/ mice (Fig. 3A).
Diuresis was larger in mice with a high NaCl intake and not
different between genotypes (Fig. 3B). Urine K excretion was
not different between groups (interaction genotype diet; P
0.04), whereas Na excretion was significantly elevated on
high-salt diet (Fig. 3, C and D). On a low-salt diet, urine
osmolality was significantly lower in COX-2/ compared with
COX-2/ (763 39 and 2,158 184 mosmol/kg H2O, respec-
tively). A high-salt diet caused a lower urine osmolality com-
pared with low-salt diet in COX-2/ (1,538 90 and 2,158 184
mosmol/kg H2O, respectively), whereas urine osmolality was
not significantly changed with salt intake in COX-2/mice [763
39 (LS) and 1,379  182 (HS) mosmol/kg H2O, respectively].
Total osmolal excretion was significantly higher with a high
NaCl intake and not different between genotypes (Fig. 3E).
With low-salt diet, plasma renin concentration increased com-
pared with high NaCl in both genotypes. At low NaCl intake,
COX-2/ mice exhibited a lower plasma renin concentration
compared with COX-2/ (Fig. 3F). There was no significant
difference in plasma renin concentration between genotypes
after a high NaCl intake (Fig. 3F) (interaction genotype  diet;
P  0.04). The plasma concentration of the prostacyclin metab-
olite 6-keto-PGF1 in samples from COX-2/ and COX-2/
on high-salt (COX-2/: 0.51  0.14 and COX-2/: 0.29 
0.09 ng/ml) and low-salt diet (COX-2/: 0.43  0.14 and
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Fig. 2. Effect of HS and LS diet (HS, 4%
NaCl and LS, 0.004% NaCl, 18 days) on
diurnal variation in MAP and MAP data
separated by sex in conscious, freely moving
COX-2/ and COX-2/ mice. A: MAP
averaged for all day and night recordings
during the whole period of observation (day
14-night 17, postsurgery) in COX-2/ and
COX-2/ mice on HS and LS diet. B: differ-
ence in MAP between day and night (diurnal
variation) averaged from days 14 to 17 in
COX-2/ and COX-2/ mice on HS and
LS diet. C: MAP averaged for night and day
between male (n  6) and female (n  4)
COX-2/ mice on LS diet. D: average
MAP for male (n  6) and female (n  5)
COX-2/ mice on HS diet. E: average night
and day MAP for male (n  4) and female
(n 4) COX-2/ mice on LS diet. F: average
night and day MAP in male (n  5) and
female (n  5) COX-2/ mice on HS diet.
Bar graphs depict means  SE. There were
no differences in blood pressure between
male and female mice of either genotype.
Statistical evaluation was performed by two-
way ANOVA followed by Bonferroni post
hoc test. *Statistically significant difference
between groups at P 	 0.05 (Bonferroni
multiple comparison post hoc test). P values
for interaction (I), genotype (G), and diet (D)
for B: I, 0.01; G, P 	 0.0001; and D, P 	
0.0001.
R902 COX-2, NaCl, AND BLOOD PRESSURE
AJP-Regul Integr Comp Physiol • doi:10.1152/ajpregu.00103.2012 • www.ajpregu.org
 by 10.220.32.247 on February 5, 2017
http://ajpregu.physiology.org/
D
ow
nloaded from
 
COX-2/: 0.55 0.16 ng/ml) was not changed significantly by
either salt diet or genotype.
Plasma and urinary excretion of NOx, cGMP, cAMP, and
ANP mRNA expression. Urine NOx and cGMP excretions were
elevated significantly and to a similar extent in COX-2/ and
COX-2/ on high-salt diet (Fig. 4, A and B) (NOx interaction
genotype  diet; P 	 0.0001), whereas high-salt diet did not
affect plasma NOx and cGMP concentration significantly (Fig.
4, C and D). The urine excretion of cAMP was significantly
elevated in COX-2/ by the high-salt diet. In mice fed the
low-salt diet, it was significantly increased in COX-2/ com-
pared with COX-2/. In COX-2/ the high-salt diet did not
affect cAMP urine excretion significantly (Fig. 4E) (interaction
genotype  diet; P  0.0002). High-salt diet did not affect the
level of ANP mRNA in the heart (left ventricle) significantly
(Fig. 4F).
Renal and vascular expression of NOS isoforms and COX-2.
High-salt diet did not cause significant changes in mRNA levels
of eNOS or iNOS in the medulla, cortex, or aorta (Table 2). nNOS
mRNA level was elevated significantly in the kidney cortex of
COX-2/ independently of salt diet compared with wild-type
mice (Fig. 5B, nNOS primers covered a region that is con-
served in the multiple known splice variants), whereas no other
significant changes in nNOS were observed in kidney medulla
and aorta (Fig. 5, A and C). COX-2 mRNA level was not
changed in the kidney medulla (Fig. 5D), but it was signifi-
cantly reduced by a high-salt diet in the kidney cortex and aorta
of wild-type littermates (Fig. 5, E and F). COX-2 was not
amplified with cDNA template from COX-2/ mice. The
abundance of total eNOS and of phospho-Thr495-eNOS pro-
teins in the kidney medulla was not affected by either salt diet
or genotype (Fig. 5, G and H).
DISCUSSION
The major findings of the present study are the following:
1) Global COX-2 deletion in mice on a C57BL6 background
results in a significant elevation of arterial blood pressure,
irrespective of salt intake and plasma prostacyclin; 2) C57BL6
mice display NaCl-sensitive blood pressure; 3) a specific
“NaCl sensitivity” of arterial blood pressure associated with
COX-2 was observed during dark periods (which corresponds to
the awake, active period), where chronic salt intake caused a
larger increase in arterial blood pressure in COX-2/; 4) differ-
ences in arterial blood pressure presumably reflect changes in
peripheral resistance as the diurnal changes in heart rate were
comparable in the different experimental groups; 5) There were
no differences in blood pressure between male and female mice in
any group; and 6) COX-2 activity does not drive renal medullary
NO synthesis.
Thus COX-2 activity protects against increases in arterial
blood pressure and in particular attenuates an increase in blood
pressure associated with the active awake phase of the mice
(darkness) during chronic high salt intake. This was reflected
by cardiac hypertrophy in adult COX-2/ mice. In mechanis-
tic terms, the high-salt diet had no effect on medullary eNOS
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Fig. 3. Effect of HS and LS diet (0.004 vs. 4%, 18 days) on diuresis, urine osmolality, urine K excretion, urine Na excretion and plasma renin concentration
in COX-2/ and COX-2/ mice. Mice were placed in metabolic cages on days 13–17 of the salt diet, and 24-h urine was collected on day 16 and 17 (n 
6 in each group). At the end of the experiment, mice were anesthetized and a blood sample was taken. A: water intake; B: diuresis; C: urinary K excretion;
D: urinary Na excretion; E: urinary osmolal excretion; F: plasma renin concentration. Bar graphs depict means SE. Statistical evaluation by two-way ANOVA
followed by Bonferroni post hoc test. *Statistically significant difference between groups at P 	 0.05 (Bonferroni multiple comparison post hoc test). P values
for interaction (I), genotype (G), and diet (D) are the following. A: I, 0.09; G, P  0.1; and D, P 	 0.0001, B: I, 0.2; G, P  0.1; and D, P 	 0.0001. C: I,
0.04; G, P  0.4; and D, P  0.3. D: I, 0.3; G, P  0.3; and D, P 	 0.0001. E: I, 0.2; G, P  0.4; and D, P 	 0.0001. F: I, 0.04; G, P 	 0.0001, and D,
P 	 0.0001.
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synthase mRNA level and protein abundance, whereas surro-
gate markers for renal NO production increased to a similar
degree in both genotypes as judged by the augmented nitrite
and cGMP excretions. Since plasma levels of NOx and cGMP
and cardiac ANP expression were not altered, the marked
increase in urinary excretions of NOx and cGMP most likely
reflects local, renal NO synthesis. COX-2/ mice exhibited
no systemic indices of prostacyclin deficiency, and COX-2
activity therefore does not appear necessary for systemic for-
mation of this prostanoid and for the NaCl-induced stimulation
of NO production in the renal medulla. The present findings
also imply that, in the normal mouse, at the systemic level, if
chronic salt intake increases the availability of arachidonic
acid, the fatty acid is likely to be metabolized primarily
through COX-1.
The increase in urinary cAMP excretion caused by chronic salt
loading observed in wild-type mice was absent in COX-2/
mice. The cAMP excretion in COX-2/ mice on low salt was
higher compared with COX-2/ on low salt. COX-2/ have
elevated vasopressin expression already at baseline (25), which
may account for the present lack of reactivity of cAMP to the
stimulation of elevated NaCl.
Despite homeostatic suppression of renin and natriuresis, an
increased dietary NaCl intake precipitated hypertension in
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Fig. 4. Effect of HS and LS diet (18 days, 0.004 vs. 4% NaCl) on urine excretions and plasma concentration of NOx, cGMP, and cAMP and atrial natriuretic
peptide (ANP) mRNA expression in heart (left ventricle) in COX-2/ and COX-2/ mice. Mice were placed in metabolic cages on days 13–17 of the HS and
LS diet. The 24-h urine samples used for analyses were collected on days 16 and 17 (n 6 in each group). A: urinary NOx excretion; B: urinary cGMP excretion;
C: plasma NOx level; D: plasma cGMP level; E: urinary cAMP excretion; F: cardiac tissue ANP mRNA level. Bar graphs depict means  SE. Statistical
evaluation was performed by two-way ANOVA followed by Bonferroni post hoc test. *Statistically significant difference between groups at P	 0.05 (Bonferroni
multiple comparison post hoc test). P values for interaction (I), genotype (G), and diet (D) are the following. A: I, 0.8; G, P  0.03; and D, P 	 0.0001. B: I,
0.1; G, P  0.2; and D, P 	 0.0001. C: I, 0.3; G, P  0.8; and D, P  0.3. D: I, 0.2; G, P  0.9; and D, P  0.8. E: I, 0.0002; G, P  0.9; and D, P 	 0.007.
F: I, 0.2; G, P  0.9; and D, P  0.4.
Table 2. Messenger RNA levels for eNOS and iNOS
mRNA Ratio, 103
COX-2/ COX-2/
Low salt High salt Low salt High salt
Kidney medulla
eNOS/GAPDH 8.32 0.60 9.59  1.69 7.59  0.74 7.83  1.50
iNOS/GAPDH 100.6 43.67 67.53  9.82 39.36  2.85 46.6  10.41
Kidney cortex
eNOS/GAPDH 2.79 0.52 4.31  1.18 2.97  0.39 2.41  0.40
iNOS/GAPDH 31.1 10.49 33.87  11.42 19.05  5.45 22.48  8.91
Aorta
eNOS/GAPDH 6.99 1.73 15.08  2.77 10.19  2.39 15.5  2.35
iNOS/GAPDH 38.8 9.96 61.26  9.73 42.63  7.19 44.07  3.93
Values are means SE. Messenger RNA levels for eNOS and iNOS in kidney medulla, cortex, and aorta as measured by qRT-PCR in tissues from COX-2/
and COX-2 / mice on high- (4%) and low- (0.004%) salt diet (n  6–8 in each group). Tissue was harvested from mice on day 18 of salt diet. Messenger
RNA levels are shown relative to GAPDH.
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wild-type C57BL6 mice, as observed previously (6), and as
observed in mice with disruption of eNOS, COX-1, IP, and
EP2 receptors, and mPGES-1/ (7, 14, 17, 19). IP, EP2, and
EP4 receptors are Gs-coupled adenylyl cyclase-activating re-
ceptors associated with the vasa recta, the medullary collecting
ducts, and the descending limb of the loop of Henle. Because
PGE2 appears to drive NO synthesis in the medulla (14),
because prostacyclin and PGE2 cause vasodilatation by acti-
vating eNOS (11, 31), and because local inhibition of NO
synthase and COX-2 in the renal medulla increase blood
pressure in response to high salt, a serial coupling may exist
between NaCl-sensitive renomedullary COX-2 activity and
renal NO synthesis by eNOS. The present results demonstrate
that COX-2 expression in the mouse renal medulla of C57BL6
mice does not display the same direct correlation with salt
intake as observed in, for example, the rat kidney medulla (12,
39), and that COX-2 deletion does not decrease the abundance
of eNOS mRNA and protein. The overall renomedullary NO
production, to judge from the increased urine NOx and cGMP
excretions, increased in response to chronic high NaCl in a
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Fig. 5. Messenger RNA levels for neuronal nitric oxide synthase (nNOS) in kidney medulla (A), kidney cortex (B), and aorta (C) and for COX-2 in kidney medulla
(D), kidney cortex (E), and aorta (F) as measured by RT-qPCR in tissues from COX-2/ and COX-2/ mice on HS (4%) and LS (0.004%) diet (n  6–8
in each group). Tissues were harvested from mice with chronic indwelling arterial catheters on day 18 of salt diet. Messenger RNA levels for nNOS and COX-2
are shown relative to level of GAPDH. Immunoblotting and densitometric semiquantification of protein levels of total endothelial NOS (eNOS) (G) and
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similar fashion in the presence or absence of COX-2. The
statistical interaction between genotype and NaCl intake with
NOx as variable suggest a complex interaction, however, that
is not uncovered by the present approach. This observation
then implies that the dependency on mPGES-1 activity of NO
formation, unmasked in mPGES-1/ (14), is not at the level
of COX-2. Because COX-1 is expressed at higher levels in the
renal medulla of COX-2/ (39) and COX-1 deletion attenu-
ated NOx excretion and increased blood pressure in mice (15),
the COX-1 isoform must compensate for the loss of COX-2
and provide substrate for mPGES-1. Redundancy between
COX-1 and COX-2 in the medulla with mPGES-1 as a com-
mon downstream mediator is therefore a highly likely expla-
nation for the discrepancy between data on NO indices and
cGMP excretion obtained in salt-loaded COX-1/ and
mPGES-1/ mice (14) and the present results in COX-2/
animals. Although COX-1 may support NO synthesis in the
medulla of COX-2/, the present observation that blood
pressure is not protected fully by COX-1 in the absence of
COX-2 when mice are challenged by high salt intake is in
accord with data from mice where COX-2 was replaced glob-
ally by COX-1. This precipitated hypertension in response to
increased NaCl intake (41). A logical conclusion is that the
increase in arterial blood pressure caused by chronic high salt
intake in active, COX-2/ mice is not likely to be caused by
attenuated renal NO signaling.
As originally observed (4, 24) and later confirmed (38),
COX-2/ mice display a renal developmental defect with
fewer and immature, last-generation, subcapsular, nephrons
and juxtamedullary glomerular hypertrophy. This defect is less
pronounced in C57BL6 mice than in mice with other genetic
backgrounds (38). Accumulation of small subcapsular glomer-
uli was typical and fibrosis was noted in some mice in the
present study. Therefore, the elevated pressure in COX-2/
mice could be secondary to the kidney tissue injury. On the
other hand, a COX-2 knockdown strategy in C57BL6 mice
showed mild renal functional and structural injury with ele-
vated blood urea nitrogen (BUN), similar to the present mice
(30), while telemetric blood pressure recordings showed blood
pressure in adult COX-2 knockdown mice not different from
COX-2/ and with no circadian variation (30). Other murine
models with a comparable minor developmental nephron def-
icit have an elevated arterial blood pressure (2). Similarly, in
the rat, postnatal nephron deficit induces hypertension (35)
while it stimulates the renin-angiotensin system (32). The
present findings confirm that COX-2 deletion is associated with
attenuated renin secretion after low salt (18, 37), while high
salt led to similar suppression. Thus the renin system reacts
adequately to extra NaCl intake considering a higher blood
pressure in COX-2/, which indicates that the renin-angio-
tensin system is less likely causal for the elevated pressure. An
unexpected finding of the present study was that high NaCl
intake precipitates a significant elevation in blood pressure
during the awake phase (darkness period), and this increase
was significantly larger in COX-2/ compared with all other
groups. However, the statistical significant interaction between
genotype and salt intake with delta pressure as dependent
variable suggests a complex interplay. COX-2 is expressed in
the hypothalamus (25). COX-1/ mice on normal salt diet
also display altered diurnal variations of blood pressure. Im-
paired regulation of the circadian clock may contribute to
cardiovascular disease (15, 28) and targeted deletion of two
hypothalamic clock components results in salt-sensitive hyper-
tension (5). Such enhanced effect of salt on blood pressure
during the awake phase is also seen in eNOS/ mice on
high-salt diet (21).
Perspectives and Significance
The present study shows a salt intake-dependent increase in
MAP10 mmHg with largest surge during the awake phase in
the conventional lab mouse strain C57BL6 mice. Furthermore,
the findings indicate that functional deletion of COX-2 in-
creases blood pressure at both low and high salt intakes and
that COX-2 activity attenuates particularly the rise in nocturnal
blood pressure in mice chronically exposed to high salt.
Chronic high NaCl intake leads to increased renal production
of NO that is not dependent on COX-2. A serial coupling
between COX-2 and eNOS in the renal medulla is not neces-
sary to moderate arterial blood pressure during high NaCl
intake.
COX-2 is necessary to allow blood pressure homeostasis in
response to salt loading, and the effect of COX-2 does not
depend on prostacyclin and NO but may involve early effects
on renal development.
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